Solta Medical (SLTM) Reaffirms Q4 Expectations

January 9, 2012 6:58 AM UTC
Get Alerts SLTM Hot Sheet
Price: $2.92 --0%

Today's EPS Names:
More
Join SI Premium – FREE
Solta Medical, Inc. (NASDAQ: SLTM) today reiterated the company's expectations for its financial results for the fourth quarter ended December 31, 2011 as follows:

  • The company expects revenue for the fourth quarter of 2011 to be $32 million to $34 million, versus the consensus of $33.22 million. Revenue for the full year 2011 is expected to be in the range of $115 million to $117 million, versus the consensus of $116.03 million.
  • Non-GAAP gross margin is expected to be in the range of 66% to 68% for the full year 2011. Non-GAAP gross margin excludes non-cash amortization charges, non-cash stock based compensation charges, and acquisition related adjustments.
  • The company expects to generate positive non-GAAP EBITDA for the fourth quarter and for the full-year 2011. Non-GAAP EBITDA excludes non-cash amortization charges, non-cash stock based compensation charges, and acquisition related adjustments.


In addition, the company expects to report a cash balance as of December 31, 2011 of approximately $17 million and that it had drawn a total of approximately $25 million from credit facilities with Silicon Valley Bank to facilitate the acquisition of Liposonix that occurred in November.

The Company plans to report fourth quarter and full year 2011 financial results on Monday, February 13, 2012.

The company confirmed its initial financial outlook for the fourth quarter due to management's participation in the Needham Conference and investor meetings during the JP Morgan Conference held in San Francisco next week.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Guidance

Related Entities

JPMorgan, Needham & Company, Earnings